Let’s do something about
PRURIGO NODULARIS (PN).
The STOP-PN Study is evaluating a new oral medication for adults with PN.
THE STOP-PN CLINICAL STUDY - NOW ENROLLING
Prurigo nodularis (PN) is a skin condition characterized by itchy lesions or nodules that may be on the arms, legs, chest and back. These nodules are so itchy that they trigger a vicious cycle of repeated scratching, bleeding, and scarring that can last for years. As a result, PN can greatly impact quality of life, affecting everything from sleep quality, to work performance, to social interactions.
Currently, there is no cure for prurigo nodularis, but doctors and researchers are studying new options that may be able to help.
If you’ve had prurigo nodularis for at least 3 months, you may qualify for a new clinical study now being conducted at select centers in the US, Canada, Europe, and Australia (called the STOP-PN Study). The study is evaluating a new oral medication for prurigo nodularis, taken once daily. If you qualify and choose to join the study, you may be able to use the study medication for up to 12 months at no cost to you.
WHY PARTICIPATE?
If you struggle with prurigo nodularis, you may qualify for the STOP-PN Clinical Study. The study is evaluating a new medication for prurigo nodularis, taken once daily for up to 12 months.
If you qualify and choose to join the STOP-PN Study you will receive:
- Evaluations of your prurigo nodularis from a local physician specialist
- Study-related care and study medication at no cost
- Compensation for your time and travel to attend any required study visits over an approximate 12-month period
- The opportunity to help advance potential treatment options for prurigo nodularis, which may benefit other PN sufferers in the future
SEE IF YOU QUALIFY
To see if you might qualify for the STOP-PN Study, and to get connected with your local study center to learn more, please take the pre-screening questionnaire below.